Liberman Alexander M.

Chief Legal OfficerMedline Inc. (MDLN) · full profile →Form 4 · filed Mar 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
3 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Grant(A)12K$012K
Dec 16, 2025Grant(A)227K227K
Dec 16, 2025Grant(A)234K234K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Grant(A)1.1M1.1M
Dec 16, 2025Grant(A)142K142K
Dec 16, 2025Grant(A)72K72K
Dec 16, 2025Grant(A)105K105K
Dec 16, 2025Grant(A)234K234K
Dec 16, 2025Grant(A)227K227K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-096648) within minutes of acceptance. Every field above traces to the original document. Verify it directly: